Imagine your joint cartilage is like a shock absorber that has worn thin or cracked. Instead of waiting for a full joint replacement, this technology acts like a temporary, smart scaffold that fills the gap. It allows the body to regrow its own surface while letting the patient walk on the leg immediately after surgery.
Cartilage damage has minimal innate healing and leads to osteoarthritis, causing hundreds of billions of Euros in healthcare costs. Current surgical repairs often have long recovery times and complex procedures.
The COPLA biodegradable implant, which creates a weight-adaptive microenvironment for cartilage regeneration.
If you are a medical device company dealing with the high cost and complexity of cartilage repair — this project developed COPLA, a biodegradable implant that enables immediate full weight-bearing and uses existing surgical instruments.
If you are a clinic dealing with long patient recovery times and high readmission rates — this project developed a solution that allows for fast pain relief and functional recovery, reducing the need for total knee replacements.
If you are a trauma center dealing with athletes needing a quick return to sport after cartilage destruction — this project developed a science-based implant that supports early rehabilitation and long-term joint maintenance.
The product is designed as an off-the-shelf solution with favorable production economics, which guarantees affordable pricing for the healthcare system.
Yes, Askel possesses proprietary and industrially scalable in-house production capabilities to serve the large market.
The COPLA solution is based on patented technology created through multidisciplinary academic research.
It is designed for surgical simplicity, implanted in a single surgery using an easy-to-adapt technique with existing instruments.
The product allows for immediate full weight-bearing of the operated leg after surgery, enabling early rehabilitation.
The project is led by a single SME, Askel Healthcare Oy, representing a 100% industry ratio. This lean structure indicates a highly focused commercial drive, where the company manages everything from the patented research to the industrially scalable production in-house.
Contact Askel Healthcare Oy in Finland
Contact us to explore licensing or distribution partnerships for COPLA.
